Xiaoli Wei
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 1%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
-
- RNA Interference and Gene Delivery 17
- Lipid Membrane Structure and Behavior 7
- Receptor Mechanisms and Signaling 6
- Nicotinic Acetylcholine Receptors Study 5
- Biomaterials 28
- Nanoparticle-Based Drug Delivery 26
- Co-authors
- Weiyue Lu (32 shared papers)Changyou Zhan (30 shared papers)Ronnie H. Fang (17 shared papers)Liangfang Zhang (17 shared papers)Ying Man (14 shared papers)Weiwei Gao (9 shared papers)Cao Xie (17 shared papers)Jiarong Zhou (6 shared papers)
- Journals
- Journal of Controlled Release (10 papers)Advanced Materials (5 papers)ACS Applied Materials & Interfaces (4 papers)Nano Letters (4 papers)Molecular Pharmaceutics (4 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Xiaoli Wei
87 papers receiving 4.5k citations
Xiaoli Wei's Hit Papers
Peers
Comparison fields: 5 of 126
- Biomaterials 1.8k
- Biomedical Engineering 1.8k
- Pharmaceutical Science 217
- Molecular Biology 2.3k
- Microbiology 173
Countries citing papers authored by Xiaoli Wei
This map shows the geographic impact of Xiaoli Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Wei more than expected).
Fields of papers citing papers by Xiaoli Wei
This network shows the impact of papers produced by Xiaoli Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Wei. The network helps show where Xiaoli Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoli Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Engineered Cell‐Membrane‐Coated Nanoparticles Directly Present Tumor Antigens to Promote Anticancer Immunity Hit paper breakdown → | 2020 | 312 |
| 2 | 2017 | 284 | |
| 3 | 2017 | 220 | |
| 4 | 2016 | 193 | |
| 5 | 2014 | 179 | |
| 6 | 2018 | 177 | |
| 7 | 2019 | 177 | |
| 8 | 2019 | 163 | |
| 9 | 2015 | 162 | |
| 10 | 2011 | 133 | |
| 11 | 2011 | 130 | |
| 12 | 2015 | 128 | |
| 13 | 2013 | 119 | |
| 14 | 2014 | 113 | |
| 15 | 2016 | 110 | |
| 16 | 2020 | 109 | |
| 17 | 2017 | 106 | |
| 18 | 2012 | 96 | |
| 19 | 2016 | 82 | |
| 20 | 2017 | 82 |
About Xiaoli Wei
Xiaoli Wei is a scholar working on Molecular Biology, Biomaterials, Biomedical Engineering, Immunology and Oncology, having authored 90 papers that have together received 4.6k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (26 papers), RNA Interference and Gene Delivery (17 papers), Nanoplatforms for cancer theranostics (14 papers), Lipid Membrane Structure and Behavior (7 papers), Receptor Mechanisms and Signaling (6 papers), Characterization and Applications of Magnetic Nanoparticles (6 papers), Nicotinic Acetylcholine Receptors Study (5 papers) and Antimicrobial Peptides and Activities (5 papers). The work is most often cited by research in Biomaterials (1.8k citations), Biomedical Engineering (1.8k citations), Pharmaceutical Science (217 citations), Molecular Biology (2.3k citations) and Microbiology (173 citations). Xiaoli Wei has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Weiyue Lu, Changyou Zhan, Ronnie H. Fang, Liangfang Zhang, Ying Man, Weiwei Gao, Cao Xie, Jiarong Zhou, Ashley V. Kroll and Danni Ran. Their work appears in journals such as Journal of Controlled Release, Advanced Materials, ACS Applied Materials & Interfaces, Nano Letters and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.